Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5690958 | BECTON DICKINSON CO | Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life |
Sep, 2016
(7 years ago) | |
US6536975 | BECTON DICKINSON CO | Liquid applicator with opposed wings |
Nov, 2020
(3 years ago) | |
US7182536 | BECTON DICKINSON CO | Antiseptic applicator with mechanism for fracturing multiple ampoules |
Dec, 2023
(3 months ago) | |
US6991394 | BECTON DICKINSON CO | Liquid applicator with a mechanism for fracturing multiple ampoules |
Jan, 2024
(2 months ago) |
Market Authorisation Date: 14 July, 2000
Treatment: NA
Dosage: SPONGE;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
USD396911 | BECTON DICKINSON CO | Liquid applicator body |
Aug, 2012
(11 years ago) | |
US5538353 | BECTON DICKINSON CO | Liquid applicator |
Aug, 2015
(8 years ago) | |
US5690958 | BECTON DICKINSON CO | Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life |
Sep, 2016
(7 years ago) | |
US5752363 | BECTON DICKINSON CO | Method and apparatus for manufacturing liquid dispensers |
Apr, 2017
(6 years ago) | |
US5772346 | BECTON DICKINSON CO | Liquid applicator with structural insert |
Apr, 2017
(6 years ago) |
Market Authorisation Date: 14 July, 2000
Treatment: NA
Dosage: SPONGE;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5690958 | BECTON DICKINSON CO | Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life |
Sep, 2016
(7 years ago) |
Market Authorisation Date: 07 October, 2002
Treatment: NA
Dosage: SWAB;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5690958 | BECTON DICKINSON CO | Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life |
Sep, 2016
(7 years ago) | |
US6536975 | BECTON DICKINSON CO | Liquid applicator with opposed wings |
Nov, 2020
(3 years ago) | |
US6729786 | BECTON DICKINSON CO | Liquid applicator for coloring a liquid |
Mar, 2023
(1 year, 1 month ago) | |
US7241065 | BECTON DICKINSON CO | Applicator for coloring antiseptic |
Mar, 2023
(1 year, 1 month ago) | |
US7182536 | BECTON DICKINSON CO | Antiseptic applicator with mechanism for fracturing multiple ampoules |
Dec, 2023
(3 months ago) | |
US6991393 | BECTON DICKINSON CO | Liquid applicator for coloring a liquid |
Jan, 2024
(2 months ago) | |
US6991394 | BECTON DICKINSON CO | Liquid applicator with a mechanism for fracturing multiple ampoules |
Jan, 2024
(2 months ago) | |
US7422388 | BECTON DICKINSON CO | Applicator for coloring antiseptic |
Apr, 2027
(3 years from now) |
Market Authorisation Date: 14 July, 2000
Treatment: Use as an antiseptic for the preparation of a patient's skin prior to surgery
Dosage: SPONGE;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
USD468424 | PROF DSPLS | Swabstick |
Jan, 2017
(7 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
M(M-221) | Feb 14, 2021 |
Market Authorisation Date: 03 June, 2005
Treatment: NA
Dosage: SWAB;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8623935 | 3M HEALTH CARE | Antimicrobial compositions |
Jul, 2029
(5 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
M(M-292) | Jan 20, 2026 |
New Product(NP) | Aug 08, 2021 |
Market Authorisation Date: 08 August, 2018
Treatment: For the preparation of skin prior to surgery; Helps reduce bacteria that can potentially cause skin infection
Dosage: SOLUTION;TOPICAL